Shares of Exelon Corporation (NASDAQ:EXC – Get Free Report) have received an average recommendation of “Hold” from the ten brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $47.40.
A number of research analysts have recently issued reports on EXC shares. BMO Capital Markets raised their price target on shares of Exelon from $46.00 to $50.00 and gave the stock an “outperform” rating in a research report on Monday, April 28th. Guggenheim boosted their target price on shares of Exelon from $47.00 to $50.00 and gave the company a “buy” rating in a research note on Friday, May 2nd. Morgan Stanley reduced their target price on shares of Exelon from $49.00 to $48.00 and set an “equal weight” rating for the company in a research note on Thursday, May 22nd. KeyCorp lowered shares of Exelon from a “sector weight” rating to an “underweight” rating and set a $39.00 target price for the company. in a research note on Wednesday, May 14th. Finally, Wells Fargo & Company boosted their price target on shares of Exelon from $46.00 to $50.00 and gave the stock an “equal weight” rating in a research report on Friday, May 2nd.
Get Our Latest Analysis on Exelon
Exelon Trading Up 0.9%
Exelon (NASDAQ:EXC – Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.86 by $0.06. The firm had revenue of $6.71 billion for the quarter, compared to the consensus estimate of $6.30 billion. Exelon had a net margin of 11.44% and a return on equity of 10.29%. The firm’s revenue was up 11.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.68 earnings per share. As a group, equities research analysts anticipate that Exelon will post 2.64 earnings per share for the current year.
Exelon Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Monday, May 12th were paid a $0.40 dividend. The ex-dividend date was Monday, May 12th. This represents a $1.60 annualized dividend and a yield of 3.73%. Exelon’s dividend payout ratio is presently 59.48%.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the stock. Norges Bank bought a new stake in Exelon in the fourth quarter worth approximately $479,597,000. Price T Rowe Associates Inc. MD boosted its holdings in shares of Exelon by 37.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company’s stock worth $1,039,545,000 after buying an additional 7,483,873 shares during the period. Nuveen LLC bought a new stake in shares of Exelon during the 1st quarter worth $285,428,000. FMR LLC boosted its holdings in shares of Exelon by 46.9% during the 4th quarter. FMR LLC now owns 17,306,652 shares of the company’s stock worth $651,422,000 after buying an additional 5,524,103 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Exelon by 43.3% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,846,030 shares of the company’s stock worth $483,525,000 after buying an additional 3,878,687 shares during the period. Institutional investors and hedge funds own 80.92% of the company’s stock.
About Exelon
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Stories
- Five stocks we like better than Exelon
- 3 Best Fintech Stocks for a Portfolio Boost
- Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making?
- What is the Dogs of the Dow Strategy? Overview and Examples
- Value Alert: 3 High-Yield Stocks Trading at 52-Week Lows
- What is a Special Dividend?
- Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.